- Home
- FCAP vs EPRX Comparison
FCAP vs EPRX Comparison
Compare FCAP & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCAP
- EPRX
- Stock Information
- Founded
- FCAP 1891
- EPRX 2011
- Country
- FCAP United States
- EPRX Canada
- Employees
- FCAP N/A
- EPRX N/A
- Industry
- FCAP Savings Institutions
- EPRX
- Sector
- FCAP Finance
- EPRX
- Exchange
- FCAP Nasdaq
- EPRX NYSE
- Market Cap
- FCAP 161.2M
- EPRX 137.7M
- IPO Year
- FCAP 1999
- EPRX N/A
- Fundamental
- Price
- FCAP $44.21
- EPRX $5.93
- Analyst Decision
- FCAP
- EPRX Strong Buy
- Analyst Count
- FCAP 0
- EPRX 1
- Target Price
- FCAP N/A
- EPRX $12.00
- AVG Volume (30 Days)
- FCAP 29.1K
- EPRX 11.9K
- Earning Date
- FCAP 07-25-2025
- EPRX 08-07-2025
- Dividend Yield
- FCAP 2.81%
- EPRX N/A
- EPS Growth
- FCAP 2.61
- EPRX N/A
- EPS
- FCAP 3.65
- EPRX N/A
- Revenue
- FCAP $42,869,000.00
- EPRX N/A
- Revenue This Year
- FCAP N/A
- EPRX N/A
- Revenue Next Year
- FCAP N/A
- EPRX N/A
- P/E Ratio
- FCAP $11.31
- EPRX N/A
- Revenue Growth
- FCAP 6.35
- EPRX N/A
- 52 Week Low
- FCAP $28.50
- EPRX $2.20
- 52 Week High
- FCAP $53.85
- EPRX $6.20
- Technical
- Relative Strength Index (RSI)
- FCAP 38.45
- EPRX N/A
- Support Level
- FCAP $38.51
- EPRX N/A
- Resistance Level
- FCAP $42.71
- EPRX N/A
- Average True Range (ATR)
- FCAP 1.68
- EPRX 0.00
- MACD
- FCAP -0.42
- EPRX 0.00
- Stochastic Oscillator
- FCAP 30.75
- EPRX 0.00
About FCAP First Capital Inc.
First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.